References

Cui, X.P., L.F. Lee, H.D. Hunt, W.M. Reed and B. Lupiani et al., 2005. A Marek's disease virus vIL-8 deletion mutant has attenuated virulence and confers protection against challenge with a very virulent plus strain. Avian Dis., 25: 199-206.
PubMed  |  

Cui, X.P., L.F. Lee, W.M. Reed, H.J. Kung and S.M. Reddy, 2004. Marek's disease virus encoded vIL-8 gene is involved in early cytolytic infection but dispensable for establishment of latency. J. Virol., 9: 4753-4760.
PubMed  |  

Jarosinski, K.W., P.H. O'Connell and K.A. Schat, 2003. Impact of deletions within the Bam HI-L fragment of attenuated Marek's disease virus on vIL-8 expression and the newly identified transcript of open reading frame LORF4. Virus Genes, 3: 255-269.
PubMed  |  

Liu, J.L., S.F. Lin, L. Xia, P. Brunovskis and D. Li et al., 1999. MEQ and v-IL8: Cellular genes in disguise?. Acta Virol., 2-3: 94-101.
PubMed  |  

Parcells, M.S., S.F. Lin, R.L. Dienglewicz, V. Majerciak and D.R. Robinson et al., 2001. Mareks disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): Characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J. Virol., 75: 5159-5173.
CrossRef  |  Direct Link  |  

Schat, K.A. and Z. Xing, 2000. Specific and nonspecific immune responses to Marek's disease virus. Dev. Comp. Immunol., 2-3: 201-221.
PubMed  |